Clinical Trials Directory

Trials / Completed

CompletedNCT01860287

The Effects of Buprenorphine on Responses to Verbal Tasks

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In this study, the investigators will examine the effects of buprenorphine, as compared to placebo, upon physiological, subjective, and hormonal responses to a stressful speech task and a non-stressful control task in healthy adults. There is strong evidence in support of the role of endogenous opioids and opiates in mediating social behavior in humans and other animals, and particularly, in social distress. Recently it has been shown that buprenorphine, a partial mu-opioid agonist, reduces sensitivity to recognition of fearful facial expressions in humans. Here, the investigators propose to further explore the role of the opioid system in mediating stress responses in humans through the use of buprenorphine. The investigators hypothesize that buprenorphine with reduce both physiological and subjective measures of stress.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphine 0.2 MG Sublingual TabletThis is a within-subjects, double-blind, placebo-controlled experiment during which each participant will receive sublingual buprenorphine (0.2)
DRUGPlaceboThis is a within-subjects, double-blind, placebo-controlled experiment during which each participant will receive a placebo
DRUGBuprenorphine 0.4 MG Sublingual TabletThis is a within-subjects, double-blind, placebo-controlled experiment during which each participant will receive sublingual buprenorphine (0.4)

Timeline

Start date
2013-09-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2013-05-22
Last updated
2019-08-01
Results posted
2019-08-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01860287. Inclusion in this directory is not an endorsement.